Ozempic, opioid use disorder
Ozempic May Decrease Opioid Overdose Risk, Study Suggests: What To Know
Patients taking Ozempic were about 60% less likely to have an opioid overdose compared to those taking other diabetes drugs.
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the ongoing opioid epidemic.
Ozempic linked to lower opioid overdose rate in those with diabetes, study shows
The preliminary findings from this study point to the possibility that GLP-1 medications may have value in helping to prevent opioid overdoses.”
Study: Ozempic might lower risk of opioid overdose
In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people's risk of opioid overdose. People with Type 2 diabetes prescribed semaglutide (Ozempic,
Ozempic Reduced Opioid Overdose Risk, Research Shows
People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study that adds to a growing body of evidence suggesting it may help manage addiction.
Could Ozempic Help Prevent Opioid Overdoses?
In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the me
Ozempic may help manage opioid addiction: study
Those taking semaglutide were 63% less likely to overdose than those taking DPP-4 inhibitors, a widely used type of diabetes pill.
Semaglutide may reduce opioid overdoses, a new study suggests
A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.
Who’s Really Keeping Ozempic and Wegovy Prices So High?
On Tuesday, Congressional leaders spent two hours taking to task Novo Nordisk CEO Lars Fruergaard Jørgensen over the high ...
BioSpace14h
Novo’s Ozempic Seen as Shoo-In for Next Round of Medicare Price Negotiations
Novo Nordisk’s blockbuster type 2 diabetes medication is a sure bet for the list of the next 15 drugs whose Medicare prices ...
PBS19h
Lawmakers challenge drug company CEO over steep prices for Ozempic and Wegovy
Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes ...
Novo Nordisk CEO Defends Ozempic Price In Senate Testimony
A committee report found the weight loss drug is offered for less than $100 in some European countries, compared to monthly ...
Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...
Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug
Senators grilled Novo Nordisk CEO Lars Jørgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight ...